Skip to NavigationSkip to content

Pharmafile.com's weekly COVID-19 news round-up

Published on 17/06/20 at 11:23am
Photo by CDC

There is a fear of a second wave of coronavirus coming out of China, as the country reported its highest amount of cases in months as a new outbreak has been linked to a food market in Beijing. In terms of breakthrough in treatments, A US clinical trial of the drug ivermectin found that it reduced the mortality rate of COVID-19 patients by 40%.

In COVID-19 vaccine news, Moderna is to start testing 30,000 people with its coronavirus vaccine beginning in July, while Beijing-based firm Sinovac has revealed new Phase 1/2 data on its own COVID-19 vaccine, known as CoronaVac.

1. US trial of ivermectin cuts coronavirus mortality by 40% - Published 10/06/20

A US clinical trial of the drug ivermectin found that it reduced the mortality rate of COVID-19 patients by 40%.

2. Sinovac's COVID-19 vaccine successfully generates immune response at Phase ½ - Published 16/06/20

As more than 130 efforts to develop an effective vaccine against the novel coronavirus continue to roll on, Beijing-based firm Sinovac has revealed new Phase 1/2 data on its own COVID-19 vaccine, known as CoronaVac.

3. Fear of a coronavirus second wave as China reports highest number of cases in monthsPublished 15/06/20

China reported its highest amount of coronavirus cases in months as a new outbreak has been linked to a food market in Beijing.

4. Eli Lilly’s coronavirus antibody treatments could be available by SeptemberPublished 11/06/20

An antibody therapy for coronavirus could be available from Eli Lilly as early as September, according to one of its chief scientists.

5. Moderna to begin testing its COVID-19 vaccine in 30,000 people starting in JulyPublished 12/06/2020

Moderna is to start testing 30,000 people with its coronavirus vaccine beginning in July, after progressing through various trials.

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches